Cas no 105198-38-7 (2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester)
2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester Chemical and Physical Properties
Names and Identifiers
-
- Propanoic acid, 2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, ethyl ester
- 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]propanoic Acid Ethyl Ester
- ethyl 2-[tert-butyl(dimethyl)silyl]oxypropanoate
- 2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester
-
- Inchi: 1S/C11H24O3Si/c1-8-13-10(12)9(2)14-15(6,7)11(3,4)5/h9H,8H2,1-7H3
- InChI Key: KOBAXFIJEBLKRZ-UHFFFAOYSA-N
- SMILES: [Si](C)(C)(C(C)(C)C)OC(C(=O)OCC)C
Computed Properties
- Exact Mass: 232.14952
Experimental Properties
- PSA: 35.53
2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D461875-50mg |
2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]propanoic Acid Ethyl Ester |
105198-38-7 | 50mg |
$64.00 | 2023-05-18 | ||
| TRC | D461875-100mg |
2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]propanoic Acid Ethyl Ester |
105198-38-7 | 100mg |
$104.00 | 2023-05-18 | ||
| TRC | D461875-250mg |
2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]propanoic Acid Ethyl Ester |
105198-38-7 | 250mg |
$201.00 | 2023-05-18 |
2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester Related Literature
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
Additional information on 2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester
Introduction to 2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester (CAS No. 105198-38-7) and Its Emerging Applications in Chemical Biology
The compound 2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester, identified by the CAS number 105198-38-7, represents a sophisticated organosilicon derivative with significant potential in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural motifs—including a tert-butyl group, a dimethylsilyloxy moiety, and a propanoic acid ethyl ester functionality—has garnered attention for its versatile applications in synthetic chemistry, drug development, and biomolecular interactions.
At the heart of its utility lies the interplay between its steric and electronic properties. The presence of the tert-butyl group provides a robust steric shield, making it an invaluable protecting group in peptide synthesis and carbohydrate chemistry. Simultaneously, the dimethylsilyloxy (TBS) group enhances stability against hydrolysis and oxidation, a critical feature in long-term storage and biological assays. The propanoic acid ethyl ester component introduces both metabolic stability and solubility modulation, facilitating its incorporation into complex molecular architectures.
Recent advancements in synthetic methodologies have highlighted the compound's role as a key intermediate in the construction of biologically active molecules. For instance, researchers have leveraged its reactivity to develop novel protease inhibitors, where the TBS group serves as a temporary protecting moiety during peptide elongation. Additionally, its incorporation into glycosidic linkers has enabled the synthesis of glycoproteins with enhanced stability, which is particularly relevant for vaccine development and therapeutic protein engineering.
The dimethylsilyloxypropanoic acid ethyl ester moiety also plays a pivotal role in click chemistry applications. Its compatibility with azide-alkyne cycloadditions has been exploited to generate conjugates with enhanced pharmacokinetic profiles. Such derivatives exhibit improved bioavailability while maintaining target specificity, aligning with current trends toward precision medicine. Furthermore, computational studies suggest that this compound's conformational flexibility allows it to interact with biological targets in multiple ways, potentially expanding its therapeutic window.
In drug discovery pipelines, the compound has been employed as a scaffold for fragment-based drug design. Its ability to modulate both lipophilicity and charge distribution makes it an attractive candidate for generating lead compounds targeting neurological disorders. Preliminary studies indicate that derivatives of this molecule exhibit promising activity against beta-secretase enzymes implicated in Alzheimer's disease pathology. The siloxy group's ability to fine-tune solubility further enhances its suitability for oral administration or intravenous delivery.
The field of chemical biology has also embraced this compound for its utility in probe development. Researchers have synthesized fluorescent analogs where the TBS group is replaced with fluorophores or quencher moieties. These probes enable real-time imaging of biological processes such as protein-protein interactions or metabolic pathways. The stability imparted by the siloxy moiety ensures prolonged signal integrity without degradation under physiological conditions.
From an industrial perspective, the scalability of synthesizing 2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester (CAS No. 105198-38-7) remains a key consideration for commercial adoption. Advances in flow chemistry have enabled more efficient production runs while maintaining high purity standards. This scalability is essential for supporting large-scale drug trials and commercial formulations where consistency is paramount.
The environmental impact of using organosilicon compounds like this one has also been examined critically. While siloxanes are generally biodegradable under specific conditions, their persistence in certain ecosystems remains a topic of ongoing research. Efforts are underway to develop greener synthetic routes that minimize waste generation without compromising yield or purity—a balance that is increasingly scrutinized by regulatory agencies worldwide.
Looking ahead, interdisciplinary collaborations between organic chemists and bioinformaticians are expected to unlock new applications for this compound. Machine learning models trained on large datasets have begun identifying novel bioactivities associated with siloxy-containing molecules, suggesting untapped potential for therapeutic intervention. As computational power grows and experimental techniques evolve further, expect to see more innovative uses emerge from laboratories studying this versatile building block.
105198-38-7 (2-(1,1-Dimethylethyl)dimethylsilyloxypropanoic Acid Ethyl Ester) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)